Bulgaria Joins European Biobanking Research Infrastructure as Full Member
Bulgaria has joined the Biobanking and BioMolecular resources Research Infrastructure – European Research Infrastructure Consortium (BBMRI-ERIC) at its Assembly of Members, which took place in Bologna on the 23rd May 2018.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180604005699/en/
Bulgaria Joins European Biobanking Research Infrastructure as Full Member (Photo: Business Wire)
Bulgaria will be represented by the Medical University – Sofia and becomes the 21st Member. MUS is the coordinating institution of the National University Complex for Biomedical and Applied Research infrastructure, which has been part of the National Roadmap for RIs since 2014. The Ministry of Education and Science is the financial coordinator of all RIs included in the Roadmap. In the coming months, both the Bulgarian Ministry of Education and Science and MUS will work with BBMRI-ERIC to set up the BBMRI National Node.
Bulgarian Minister of Education and Science Mr Krasimir Valchev said, “I would like first to thank BBMRI-ERIC for the warm welcome of the Bulgarian biobanking and biomedical community to their European family. I am proud that we have excellent research teams who collaborate world-wide and I am convinced we should further strengthen our policies and instruments in support of our bright minds and the research and innovation development in the country. Among our European priorities are acceleration of knowledge transfer and increased access to research results, including via fostering European open science initiatives and ensuring long-term sustainability and openness of pan-European research infrastructures. Bulgaria is committed to continuing its efforts to contribute to the European research area main pillars and common goals.”
BBMRI-ERIC’s Director General Erik Steinfelder said, “It is with great pleasure I welcome Bulgaria to BBMRI-ERIC. Bulgarian biobanks are now connected to the world like never before. At the same time, Bulgarian researchers and biobankers will have access to knowledge, IT tools, and tailor-made guidance by BBMRI-ERIC that will support the further development”.
“This is also a milestone for European research in general”, Steinfelder commented. “While other countries are decreasing investment in research, Bulgaria is showing the way, boosting the development of its biomedical sector”.
Steinfelder concluded saying: “BBMRI-ERIC believes in providing services to Make New Treatments Possible, however, biomedical research does not take place in a vacuum: it requires a multidisciplinary approach. That’s why we are increasing our collaboration with other ERICs to ensure that, in the future, research infrastructures in biomedical research. That is also why we welcome the Council conclusions on accelerating knowledge circulation within the EU: we are going in the same direction”.
BBMRI-ERIC brings together more than 500 biobanks from its Members and one international organisation. The BBMRI-ERIC Directory, the largest sample catalogue in the world, allows users to search more than 100 million samples online. BBMRI’s mission is to facilitate access to biological resources and biomedical facilities and is a central player to when it comes to “Make New Treatments Possible”.
BBMRI is an international organisation established under EU legislation. Its headquarters are in Graz, Austria, and it has a liaison office in Brussels.
BBMRI-ERIC provides support and services to local biobanks via its National Nodes (one per country). The National Nodes are fully involved in the day-to-day management of BBMRI-ERIC and provide feedback from the national level. BBMRI-ERIC services cover three main areas: ethical, legal and societal issues (ELSI), quality management, and IT solutions that allow users to search collections online and request access:
BBMRI-ERIC Members: Austria, Belgium, Bulgaria, Czech Republic, Estonia, Finland, France, Germany, Greece, Italy, Malta, Latvia, the Netherlands, Norway, Poland, Sweden, United Kingdom
BBMRI-ERIC Observers: Cyprus, Switzerland, Turkey, IARC/WHO
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Life-Sciences and Healthcare Communications Leaders John “Zeke” Czekanski and Scott Roberts Join Citrus Global Healthcare Communications Group as Managing Partners21.3.2019 17:21:00 EET | Tiedote
Industry leaders John “Zeke” Czekanski and Scott Roberts have joined Citrus Global Healthcare Communications Group as Managing Partners. Zeke will oversee Citrus Scientific while Scott brings his extensive global market access and value experience in guiding Citrus Access. Together they will actively co-manage Citrus Strategy, providing insights enabling clients to innovate with confidence, broaden opportunities, and drive meaningful human-health outcomes forward. “I’m thrilled to be part of the Citrus Group working in partnership with our clients, the medical community, payers, government agencies, and global healthcare stakeholders. We look forward to delivering meaningful scientific insights and market-access solutions,” commented Zeke. Scott added, “There is a critical need in our industry, especially with highly innovative small to mid-size life-science companies, for a transformational agency applying data and analytics along with a holistic approach to the communications continu
Abzena Announces New Fully Integrated Developability and Optimization Service to Improve Lead Selection and De-risk Biologic Cell Line Development21.3.2019 16:44:00 EET | Tiedote
Abzena, the leading biologics target to GMP partner research organisation (PRO), announced its Cambridge UK site has brought together its extensive discovery, immunogenicity assessment, protein engineering, formulation, bioassay and analytical expertise to launch a developability assessment and optimization service to assist customers in selecting and developing the best lead candidate to take forward for manufacture. The new Developability Service reduces the time, risk and cost required to take multiple lead candidates through cell line development and manufacturing. Biologics have potential liabilities for safety, functionality, stability and scalability and when these issues are identified early alternate leads can be selected, liabilities engineered out or measures can be taken to mitigate risk. The Developability Service also enables the selection of drug candidates most aligned with the target product profile by evaluating a range of functionality and specificity readouts. The s
XPRIZE Identifies 10 Future Breakthroughs Required to Protect Our Forests21.3.2019 16:27:00 EET | Tiedote
Today, on the United Nations’ International Day of Forests, XPRIZE is releasing the Future of Forests Impact Roadmap, created in partnership with Kimberly-Clark Corporation. The digital report and its interactive website, based on future foresight techniques, illustrate the breakthroughs required for a healthier forest ecosystem, which might be the basis of future XPRIZE competitions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190321005409/en/ Across the world, forests provide food security and shelter, protect biodiversity and house indigenous populations. While forests cover more than 30 percent of the Earth’s surface, more than 32 million acres of forests are lost due to human activity every year, with research showing that continued mass deforestation and degradation is accelerating climate change. XPRIZE designs and operates global competitions to incentivize the development of technological breakthroughs that accel
Mark Thorne Joins BCW as Global Chief Financial Officer and Chief Operating Officer21.3.2019 16:17:00 EET | Tiedote
BCW (Burson Cohn & Wolfe), a leading global communications agency, announced today that Mark Thorne has been appointed Global Chief Financial Officer and Chief Operating Officer, effective immediately. Thorne will be a strategic partner to BCW Global CEO Donna Imperato in transforming the agency’s financial model to better reflect its wide range of services and offerings. He is based in New York and replaces Pat Przybyski, formerly Global Chief Financial Officer. “Mark is well known for his strong business acumen, deep operational experience and high-level strategic thinking,” said Imperato. “I have known Mark for many years and am thrilled to now call him my partner. He is the right leader to help BCW execute our strategies and grow exponentially.” Thorne spent the past 20 plus years with Hill+Knowlton Strategies in a range of leadership roles, most recently serving as Global Chief Financial Officer and Global Chief Operating Officer. Prior to that, Thorne was Executive Vice President
Imago BioSciences Announces $40 Million Series B Financing Led by Omega Funds21.3.2019 16:09:00 EET | Tiedote
Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, today announced a $40 million Series B financing led by Omega Funds, a leading international investment firm that creates and invests in life sciences companies. Other investors participating in the round include existing investors Frazier Healthcare Partners, Amgen Ventures, and MRL Ventures Fund as well as HighLight Capital, Pharmaron and Greenspring Associates. Dr. Dina Chaya from Omega Funds will join the board of directors and Dennis Henner will remain Chairman of the Board, representing his fund. “Imago BioSciences is extremely gratified with the interest and support of the investment community; we are particularly pleased with the composition of this new investment syndicate,” said Hugh Young Rienhoff, Jr. M.D., CEO at Imago BioSciences. “These funds will enable Imago to advance our programs through the completion of Phase 2b studies.” “We are excited to work wi
Workiva Wins DevOps Excellence Award in London21.3.2019 16:03:00 EET | Tiedote
Workiva (NYSE:WK), the leading cloud provider of connected data, reporting and compliance solutions, today announced that its Wdesk platform was named the Best Software-Defined Product, last night at Computing's DevOps Excellence Awards dinner. The Computing DevOps Excellence Awards recognize outstanding achievement from organisations, personalities and solutions operating within the DevOps industry. Winners were selected on their superior functionality, level of ability to modernize business processes, positive customer feedback and a strong return on investment. “We are proud to win this prestigious award,” said Marty Vanderploeg, CEO of Workiva. “As the global leader in connected reporting, XBRL and Inline XBRL, our Wdesk platform helps customers all over the world consolidate, connect and tag their data in a single, cloud environment so they are able to reduce risk and save time when filing reports with various regulators and other stakeholders.” XBRL (eXtensible Business Reporting
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme